Literature DB >> 19202304

The pathological role of transient receptor potential channels in heart disease.

Hiroyuki Watanabe1, Manabu Murakami, Takayoshi Ohba, Kyoichi Ono, Hiroshi Ito.   

Abstract

Transient receptor potential (TRP) channels are expressed in almost every human tissue, including the heart and vasculature. Most are permeable to Ca(2+) and play unique roles as multifunctional cellular sensors. Their involvement in many fundamental cell functions (eg, contraction, proliferation, and cell death) has made investigating their roles in human disease an urgent priority for medical science. This review presents an overview of current knowledge about the pathological role of TRP channels in heart disease and highlights some TRP channels with anticipated roles in disease. Evidence suggests that (a) upregulation of TRPC channels is involved in the development of cardiac hypertrophy and heart failure; (b) TRPC1, TRPC6, and TRPV2 play a role in the pathogenesis of cardiomyopathy associated with muscular dystrophy; (c) TRPC6 or TRPM4 is involved in the delayed after-depolarization; (d) TRPP2 is involved in the normal development of the interventricular and interatrial septa; and (e) neuronal TRPV1 acts as a detector of pain-producing stimuli. Ultimately, TRP channels might become novel pharmacological targets in the treatment of human heart disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19202304     DOI: 10.1253/circj.cj-08-1153

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  30 in total

1.  Location and function of transient receptor potential canonical channel 1 in ventricular myocytes.

Authors:  Qinghua Hu; Azmi A Ahmad; Thomas Seidel; Chris Hunter; Molly Streiff; Linda Nikolova; Kenneth W Spitzer; Frank B Sachse
Journal:  J Mol Cell Cardiol       Date:  2020-01-23       Impact factor: 5.000

2.  TRPC channels are necessary mediators of pathologic cardiac hypertrophy.

Authors:  Xu Wu; Petra Eder; Baojun Chang; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 3.  Research progress in transient receptor potential vanilloid 1 of sensory nervous system.

Authors:  Da-Lu Liu; Wen-Ting Wang; Jun-Ling Xing; San-Jue Hu
Journal:  Neurosci Bull       Date:  2009-08       Impact factor: 5.203

Review 4.  Regulation of transport in the connecting tubule and cortical collecting duct.

Authors:  Alexander Staruschenko
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

Review 5.  Vascular TRP channels: performing under pressure and going with the flow.

Authors:  David C Hill-Eubanks; Albert L Gonzales; Swapnil K Sonkusare; Mark T Nelson
Journal:  Physiology (Bethesda)       Date:  2014-09

6.  Induction of a novel cation current in cardiac ventricular myocytes by flufenamic acid and related drugs.

Authors:  R Macianskiene; A Gwanyanya; K R Sipido; J Vereecke; K Mubagwa
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

7.  Novel pharmacological approaches for antiarrhythmic therapy.

Authors:  Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-01-15       Impact factor: 3.000

8.  Single-channel analysis of TRPC channels in the podocytes of freshly isolated Glomeruli.

Authors:  Daria V Ilatovskaya; Alexander Staruschenko
Journal:  Methods Mol Biol       Date:  2013

9.  Transient Receptor Potential Canonical (TRPC)/Orai1-dependent Store-operated Ca2+ Channels: NEW TARGETS OF ALDOSTERONE IN CARDIOMYOCYTES.

Authors:  Jessica Sabourin; Fiona Bartoli; Fabrice Antigny; Ana Maria Gomez; Jean-Pierre Benitah
Journal:  J Biol Chem       Date:  2016-04-22       Impact factor: 5.157

10.  Endoglin selectively modulates transient receptor potential channel expression in left and right heart failure.

Authors:  Kevin J Morine; Vikram Paruchuri; Xiaoying Qiao; Mark Aronovitz; Gordon S Huggins; David DeNofrio; Michael S Kiernan; Richard H Karas; Navin K Kapur
Journal:  Cardiovasc Pathol       Date:  2016-08-21       Impact factor: 2.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.